by
Brendon Nafziger, DOTmed News Associate Editor | June 23, 2011
Still River Systems Inc. said Wednesday it signed a long-term licensing agreement with the Massachusetts Institute of Technology for technologies to be used with its small-footprint, single-room proton therapy system.
The agreement covers superconducting accelerator technologies developed at MIT's Plasma Science and Fusion Center in collaboration with Still River Systems, the Littleton, Mass.-based company said. Terms of the deal weren't disclosed.
Still River's first synchrotron-based proton therapy unit, called the Monarch 250, is being installed at the Barnes-Jewish Hospital, a 1,228-bed facility in St. Louis. It's expected to start treating patients next year.
Ad Statistics
Times Displayed: 30380
Times Visited: 760 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Early published figures put the total cost of equipment and construction of Still River's project at around $20 million, well shy of the $120 million to $300 million price tag of most U.S. proton therapy centers.
